Loading stock data…
Exponent (EXPO)
$61.44+1.46 (+2.43%)
Market ClosedLast close Jul 24
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Exponent, Inc. in the Industrials sector is trading at $61.44 with a market capitalization of $2.8B. Wall Street consensus targets $81.67 (3 analysts), implying a +32.9% move over the next 12 months. The stock is currently 25% below its 52-week high of $81.95, remaining 7.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +32.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $166.30M↑ | $147.43M↑ | $147.12M↑ | $141.96M↓ | $145.51M |
| Gross Profit | — | — | — | — | — |
| Operating Income | $41.38M↑ | $29.14M↑ | $29.04M↑ | $17.18M↓ | $44.43M |
| Net Income | $29.57M↑ | $24.76M↓ | $28.04M↑ | $26.55M↓ | $26.65M |
Peer Comparison
Fundamentals
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. I...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.79B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.97%
ROE
Elite ROE. Management converts capital into profit efficiently.
32.20%
Volume
Today's trading volume
437,720
Recent News
Exponent CEO Catherine Corrigan Sells 1,737 Shares
Corrigan sold exercised stock options.
Is Analyst Buzz Around Exponent’s Capital‑Light “Moat” Reframing the EXPO Investment Narrative?
Exponent, Inc. recently announced that CEO Dr. Catherine Corrigan and other senior leaders participated in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference, with a webcast made available via the company’s investor relations website. At the same time, bullish analyst and investor commentary has highlighted Exponent’s niche scientific expertise, capital‑light model, and disciplined capital allocation as key strengths supporting renewed interest in the...
Is Exponent, Inc. (EXPO) A Good Stock To Buy Now?
Is EXPO a good stock to buy? We came across a bullish thesis on Exponent, Inc. on X.com by @tomicki. In this article, we will summarize the bulls’ thesis on EXPO. Exponent, Inc.’s share was trading at $60.39 as of June 1st. EXPO’s trailing and forward P/E were 28.23 and 29.33 respectively according to Yahoo Finance. Exponent […]
1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Winners And Losers Of Q1: Exponent (NASDAQ:EXPO) Vs The Rest Of The Business Process Outsourcing & Consulting Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how business process outsourcing & consulting stocks fared in Q1, starting with Exponent (NASDAQ:EXPO).